RK

Ritesh Kumar Agrawal

Active Director Director DIN 08833303
DIN 08833303 First appointment Aug 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value •••• Premium profile

About Ritesh Kumar Agrawal

Data last updated:

Ritesh Kumar Agrawal is a Director at Mediq Pharma Private Limited (since 2020). The company operates in Trading. Mediq Pharma Private Limited reported revenue of ₹42.8 Lakh (FY 2024).

DIN 08833303
Primary Designation Director
Industry Trading
First Appointment 13 Aug 2020
Oldest Company Age 6 yrs
Largest company Mediq Pharma Private Limited · ₹42.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mediq Pharma Private Limited U51909GJ2020PTC150293
Director13 Aug 20202020₹42.8 Lakh (FY 2024)Active

Board colleagues of Ritesh Kumar Agrawal

NameDINCompanyDesignation
Gauri Shanker Agrawal08833302Mediq Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mediq Pharma Private Limited
Premium access

Shareholding and investment profile for Ritesh Kumar Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritesh Kumar Agrawal

Ritesh Kumar Agrawal currently holds 1 directorship: Mediq Pharma Private Limited (Director, since 13 Aug 2020, revenue ₹42.8 Lakh (FY 2024)).

Ritesh Kumar Agrawal was first appointed on 13 Aug 2020 as Director at Mediq Pharma Private Limited.

The current boards of Ritesh Kumar Agrawal's companies include Gauri Shanker Agrawal (Mediq Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available